Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial
暂无分享,去创建一个
D. Kavanagh | M. Vivarelli | A. Bomback | A. Trapani | M. Meier | Richard J. H. Smith | Yaqin Wang | N. Webb